Abstract
Red yeast rice is made by fermenting white rice with the fungus Monascus purpureus. It has lipid-lowering effects due to the presence of monacolin, produced by the fungus, and therefore shares the same biological and side effects as a statin, namely it may cause rhabdomyolysis. In this clinical case study, we report the case of a 50-year-old woman suffering from a sudden onset of chest discomfort and generalized myalgia. Laboratory findings were consistent with the diagnosis of rhabdomyolysis. The patient had been recently diagnosed with dyslipidemia in primary care, and decided to start eating red yeast rice, without informing clinicians. Clinical improvement was rapidly noticed after hydration, and blood sample results returned to normal. Awareness should be raised for the regulation of these products, as their consumption is rising, and patients are unaware of their potential side effects.
Keywords: statin, dyslipidemia, monacolin k, red yeast rice, rhabdomyolysis
Introduction
Nowadays, with the growing trends related to leading a healthier lifestyle, the market for natural health products is on the rise [1-2]. Red yeast rice is known for its lipid-lowering effects, due to the presence of varying amounts of natural monacolins, mainly monacolin K, which has the same chemical structure as lovastatin [3]. Both act by inhibiting HMG-CoA (5-hydroxy-3-methylglutaryl-coenzyme A) reductase and seem to share the same adverse effects [3-4]. One of its possible adverse effects is the development of rhabdomyolysis, which usually has a benign course following hydration and removal of the insulting agent [4]. Here, we describe the case of a middle-aged woman which, due to the recent diagnosis of dyslipidemia, promptly started the intake of red yeast rice. Doing so, led to the development of rhabdomyolysis without any major complication. We consider it relevant to report this case because both clinicians and patients should be aware of the potential adverse effects of these products and possible drug interactions. Clinicians should also be aware that patients often omit these products from their usual medication, as they do not recognize it as potentially harmful.
Case presentation
The patient is a female, 50-year-old, with a known past medical history of arterial hypertension and depression, under the following medication: propranolol 10 mg, venlafaxine 200 mg and diazepam 5mg, once a day each. The patient sought medical help, after a sudden onset of chest discomfort and generalized myalgia, denying any other accompanying symptoms. On admission the vital signs were stable, she had no fever, and no relevant physical findings. Relevant laboratory findings on admission and on follow-up are shown in Tables 1-2.
Table 1. Blood analysis.
Rhabdomyolysis pattern with normal liver and renal function tests. Thyroid function is also normal.
Laboratory tests | Results | On follow-up | Reference values |
Creatine phosphokinase (IU/L) | 5163 | 81 | 30–145 |
Creatine phosphokinase – MB (ng/mL) | 2.30 | 1.80 | 0–4.9 |
Lactate dehydrogenase (IU/L) | 330 | 146 | 120–246 |
Myoglobin (ng/mL) | 221 | 50 | 25–72 |
Troponin I (pg/mL) | 2.1 | 1.3 | <15.6 |
Urea (mg/dL) | 34 | 41 | 10–50 |
Creatinine (mg/dL) | 0.64 | 0.77 | 0.55–1.02 |
Alanine transaminase (IU/L) | 27 | 28 | <55 |
Aspartate transaminase (IU/L) | 20 | 23 | <34 |
Thyroid-stimulating hormone (mU/L) | 1.74 | - | 0.36–4.94 |
Free thyroxine 4 (ng/dL) | 0.91 | - | 0.7–1.48 |
Table 2. Urinalysis results on admission and on follow-up.
Urinalysis | Results | On follow-up | Reference values |
Color | Pale yellow | Pale yellow | - |
Clarity | Clear | Clear | - |
pH | 6.5 | 6.0 | - |
Specific gravity | 1.008 | 1.011 | - |
Glucose | Negative | Negative | Negative |
Blood | Negative | Negative | Negative |
Ketones | Negative | Negative | Negative |
Protein | Negative | Negative | Negative |
Urobilinogen | Negative | Negative | Negative |
Bilirubin | Negative | Negative | Negative |
Leukocyte esterase | Negative | Negative | Negative |
Nitrite | Negative | Negative | Negative |
Urine microscopy | |||
White blood cells | 2 to 5 per high-power field | 8 to 5 per high-power field | 0 to 5 per high-power field |
Red blood cells | 0 to 4 per high-power field | 0 to 4 per high-power field | 0 to 4 per high-power field |
Squamous epithelial cells | None | Some | None |
Due to high levels of serum creatine phosphokinase (CK), the patient was asked again about her habits, daily exercise activities, and recent intake of unprescribed health products. The patient then mentioned she had been recently diagnosed with dyslipidemia by her general practitioner and had decided not to start oral statins, opting for lifestyle modifications, engaging in regular physically activity and diet restrictions. In this process, the patient bought red rice yeast, and had been eating it at least for the three days prior to admission.
The patient was placed under IV fluids and monitored for liver or kidney injury as serum CK values dropped. Apart from hydration, alkalinizing the urine is recommended in the case of higher levels of CK, to prevent myoglobin deposition and damage to the renal tubules. As the analytical evolution was favorable, the patient was discharged, advised to stop red yeast rice consumption and to keep hydrated. The patient was re-evaluated 2 weeks later, maintaining clinical and analytical stability, as shown in Figures 1-2.
Figure 1. Serum CK, LDH, and myoglobin decreasing levels over a 2-week period.
LDH, lactate dehydrogenase; CK, creatine phosphokinase
Figure 2. Serum troponin and CKMB levels.
Evolution from admission to discharge.
CKMB, creatine phosphokinase MB
Discussion
According to Lin et al., the regular intake of red yeast rice 600 mg twice daily reduces serum concentrations of low-density lipoprotein cholesterol ( LDL-C) by 27.7%, total cholesterol by 21.5%, triglycerides by 15.8%, and apolipoprotein B by 26%, after 8 weeks [5]. Compared to a daily dose of low intensity statin, such as 20 mg of lovastatin, in which case the LDL-C lowering efficacy has been reported to be less than 30% in average, the results are similar [6-7].
Red yeast rice efficacy is not only due to the presence of monacolins but also because it contains ergosterol, amino acids, flavonoids, trace elements, alkaloids, sterols, isoflavones, and monounsaturated fatty acids which improve the lipid profile [8]. Its ingestion could be a relatively safe therapeutic option in dosages of 800-4800 mg/day, if a highly purified and certified red yeast rice is used [8]. Unfortunately, its safety profile is dubious, as dietary supplements are not as adequately tested or regulated as medical drugs, hence the quantity and quality of ingredients vary [3, 9]. This variation is enough to provoke undesired side effects like acute kidney injury and hepatotoxicity with a seemingly regular dose [10-11]. It also raises concern regarding drug interactions, in particular those that cause inhibition of cytochrome P450 3A4, potentiating the side effects of monacolin [4, 7]. In this case, fortunately, our patient’s medication did not significantly interact with monacolin.
We would like to highlight, besides drug interactions, two medical conditions which increase the susceptibility to statin induced rhabdomyolysis and should be considered in this case. These are untreated hypothyroidism, for which the screening was normal, and vitamin D deficiency [12-13]. Other predisposing factors that can aggravate the toxicity of myoglobin are older age, frailty, multisystem diseases, impaired liver function, and impaired kidney function (such as chronic kidney disease) [12].
In the case presented, the patient suffered complaints of myalgia due to rhabdomyolysis without any other organ disfunction and had a favorable clinical evolution following hydration and drug discontinuation. Alkalizing the urine is recommended as part of the treatment for rhabdomyolysis, if CK values are above 6000 IU/L and if in the presence of risk factors to kidney tubular lesion [14]. This patient presented borderline CK values on admission, and no other risk factors. Hence, clinicians opted for vigorous IV hydration only.
Since there is a growing tendency for overall consumption of natural products, awareness should be raised for potential side effects, drug interactions, and the need for regulation [2-3]. Clinicians, as vessels for health education [15], should ask patients specifically about the consumption of these products, as they might not recognize it as part of their regular medication or its potential side effects, thereby omitting it and consequently interfering with the diagnostic approach and unknowingly continue exposure to these substances.
Conclusions
This case regards a patient with complaints of myalgia due to rhabdomyolysis induced by the consumption of red yeast rice, without any other organ disfunction, and with a favorable clinical outcome. Although less effective than statins, serum cholesterol levels lower with regular intake of red yeast rice. Awareness should be raised for potential side effects, drug interactions, and the need to regulate these products. Thus, clinicians should ask patients specifically about the consumption of these products, as they tend to omit it from their regular medication and help provide adequate health education to consumers.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained or waived by all participants in this study
References
- 1.The Canadian Natural Health Products (NHP) regulations: industry perceptions and compliance factors. Laeeque H, Boon H, Kachan N, Cohen JC, D'Cruz J. BMC Health Serv Res. 2006;6:63. doi: 10.1186/1472-6963-6-63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Ekor M. Front Pharmacol. 2014;4:177. doi: 10.3389/fphar.2013.00177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia. Klimek M, Wang S, Ogunkanmi A. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697909/ P T. 2009;34:313–327. [PMC free article] [PubMed] [Google Scholar]
- 4.Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system. Mazzanti G, Moro PA, Raschi E, Da Cas R, Menniti-Ippolito F. Br J Clin Pharmacol. 2017;83:894–908. doi: 10.1111/bcp.13171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Efficacy and safety of Monascus purpureus went rice in subjects with hyperlipidemia. Lin CC, Li TC, Lai MM. Eur J Endocrinol. 2005;153:679–686. doi: 10.1530/eje.1.02012. [DOI] [PubMed] [Google Scholar]
- 6.2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Stone NJ, Robinson JG, Lichtenstein AH, et al. Circulation. 2014;129:0. doi: 10.1016/j.jacc.2013.11.002. [DOI] [PubMed] [Google Scholar]
- 7.Interaction between Red Yeast Rice and CYP450 Enzymes/P-glycoprotein and its implication for the clinical pharmacokinetics of lovastatin. Chen CH, Uang YS, Wang ST, Yang JC, Lin CJ. Evid Based Complement Alternat Med. 2012;2012:127043. doi: 10.1155/2012/127043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Rakel D, Abel R, Houston M. Integrative Medicine . Pennsylvania: Elsevier; 2018. Chapter 27 - Dyslipidemia; pp. 264–275. [Google Scholar]
- 9.Variability in strength of red yeast rice supplements purchased from mainstream retailers. Cohen PA, Avula B, Khan IA. Eur J Prev Cardiol. 2017;24:1431–1434. doi: 10.1177/2047487317715714. [DOI] [PubMed] [Google Scholar]
- 10.Acute liver injury induced by red yeast rice supplement. Loubser L, Weider KI, Drake SM. BMJ Case Rep. 2019;12:0. doi: 10.1136/bcr-2018-227961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.[Red yeast rice as the presumed cause of acute kidney and liver failure] Peterslund P, Christensen HD, Urbahnke J, Cappeln AV. https://pubmed.ncbi.nlm.nih.gov/31566178/ Ugeskr Laeger. 2019;181:0. [PubMed] [Google Scholar]
- 12.Statin-induced rhabdomyolysis: a comprehensive review of case reports. Mendes P, Robles PG, Mathur S. Physiother Can. 2014;66:124–132. doi: 10.3138/ptc.2012-65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Vitamin D serum levels in patients with statin-induced musculoskeletal pain. Pennisi M, Di Bartolo G, Malaguarnera G, Bella R, Lanza G, Malaguarnera M. Dis Markers. 2019;2019:3549402. doi: 10.1155/2019/3549402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Factors predictive of acute renal failure in rhabdomyolysis. Ward MM. Arch Intern Med. 1988;148:1553–1557. [PubMed] [Google Scholar]
- 15.Improving health outcomes through patient education and partnerships with patients. Paterick TE, Patel N, Tajik AJ, Chandrasekaran K. Proc (Bayl Univ Med Cent) 2017;30:112–113. doi: 10.1080/08998280.2017.11929552. [DOI] [PMC free article] [PubMed] [Google Scholar]